DK336986D0 - Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner - Google Patents

Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner

Info

Publication number
DK336986D0
DK336986D0 DK336986A DK336986A DK336986D0 DK 336986 D0 DK336986 D0 DK 336986D0 DK 336986 A DK336986 A DK 336986A DK 336986 A DK336986 A DK 336986A DK 336986 D0 DK336986 D0 DK 336986D0
Authority
DK
Denmark
Prior art keywords
procedure
biologically active
growth hormones
active recombinant
recombinant growth
Prior art date
Application number
DK336986A
Other languages
English (en)
Other versions
DK173165B1 (da
DK336986A (da
Inventor
Alvin M Janski
Ren-Der Yang
Original Assignee
Int Minerals & Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Minerals & Chem Corp filed Critical Int Minerals & Chem Corp
Publication of DK336986D0 publication Critical patent/DK336986D0/da
Publication of DK336986A publication Critical patent/DK336986A/da
Application granted granted Critical
Publication of DK173165B1 publication Critical patent/DK173165B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK198603369A 1985-07-15 1986-07-15 Implantat med reguleret frigivelse til administration af et rekombinant protein med væksthormonaktivitet samt fremgangsmåde DK173165B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/755,093 US4786501A (en) 1985-07-15 1985-07-15 Cylindrical implants for the controlled release of growth hormones
US75509385 1985-07-15

Publications (3)

Publication Number Publication Date
DK336986D0 true DK336986D0 (da) 1986-07-15
DK336986A DK336986A (da) 1987-01-16
DK173165B1 DK173165B1 (da) 2000-02-21

Family

ID=25037706

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198603369A DK173165B1 (da) 1985-07-15 1986-07-15 Implantat med reguleret frigivelse til administration af et rekombinant protein med væksthormonaktivitet samt fremgangsmåde

Country Status (18)

Country Link
US (1) US4786501A (da)
EP (1) EP0210039B1 (da)
JP (2) JPH0822820B2 (da)
KR (1) KR930008952B1 (da)
CN (1) CN1026862C (da)
AT (1) ATE84707T1 (da)
AU (1) AU604639B2 (da)
BR (1) BR8603315A (da)
CA (1) CA1288196C (da)
DE (1) DE3687551T2 (da)
DK (1) DK173165B1 (da)
ES (1) ES2002099A6 (da)
IE (1) IE62302B1 (da)
IL (1) IL79403A0 (da)
MX (1) MX173196B (da)
NZ (1) NZ216832A (da)
PT (1) PT82978B (da)
ZA (1) ZA865271B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137874A (en) * 1985-07-29 1992-08-11 American Cyanamid Co. Partially coated C10 -C20 fatty acid salts of peptides having molecular weights up to about 5,000
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4837202A (en) * 1987-09-14 1989-06-06 Pitman-Moore, Inc. Method for stimulating the immune system
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
ATE130195T1 (de) * 1988-07-26 1995-12-15 Univ Rutgers Vorrichtungen und verfahren zur wachstumsförderung bei bratgeflügel.
US5179080A (en) * 1989-08-31 1993-01-12 Clinical Homecare, Corp. Formulations containing growth hormone and nutritional supplements, and methods of treating malnutrition in chronic lung disease
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
US5232708A (en) * 1990-06-20 1993-08-03 Monsanto Company Coated veterinary implants
US5922342A (en) * 1990-10-01 1999-07-13 Pharmacia & Upjohn Company Lateral edge coated controlled release pharmaceutical compositions
IS3778A7 (is) * 1990-10-31 1992-05-02 Amgen Inc. Aðferð til að gefa dýrum vaxtarhormón, þar sem gefnu magni er stýrt
SE9303068D0 (sv) * 1993-09-21 1993-09-21 Kabi Pharmacia Ab New use
DE69420872T2 (de) * 1994-06-17 2000-01-13 Applied Research Systems Hgh enthaltende pharmazeutische zubereitungen
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
IT1269221B (it) 1994-11-25 1997-03-21 Fondazione Clinica Del Lavoro Campionatore diffusivo a simmetria radiale di sostanze volatili, ad alta capacita' di pompaggio equivalente ed utile per il desorbimento chimico e termico.
AUPO431596A0 (en) * 1996-12-20 1997-01-23 Scientec Research Pty Ltd Apparatus and method for coating a material
AU744606B2 (en) * 1996-12-20 2002-02-28 Scientec Research Pty Ltd Apparatus and method for coating a material
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
ATE281155T1 (de) * 1998-04-20 2004-11-15 Genzyme Corp Medikamentöse verabreichung von proteinen aus polymergemischen
EP1408876A4 (en) * 2001-06-22 2004-09-22 Durect Corp ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US9763788B2 (en) 2005-09-09 2017-09-19 Board Of Trustees Of The University Of Arkansas Bone regeneration using biodegradable polymeric nanocomposite materials and applications of the same
US8936805B2 (en) 2005-09-09 2015-01-20 Board Of Trustees Of The University Of Arkansas Bone regeneration using biodegradable polymeric nanocomposite materials and applications of the same
EP1931401A2 (en) * 2005-09-09 2008-06-18 University of Arkansas at Little Rock System and method for tissue generation and bone regeneration

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) * 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US4158526A (en) * 1978-01-09 1979-06-19 General Electric Company Turbine assembly including a rotatable liquid collection ring
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
IL59690A (en) * 1980-03-24 1983-11-30 Yeda Res & Dev Production of bovine growth hormone by microorganisms and modified microorganisms adapted to produce it
IE52755B1 (en) * 1980-08-26 1988-02-17 Univ California Bovine pre-growth and growth hormone
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
DE3214667C2 (de) * 1982-04-21 1985-07-18 Akzo Gmbh, 5600 Wuppertal Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen
CA1224432A (en) * 1982-08-17 1987-07-21 Gary N. Buell Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
CA1341012C (en) * 1982-09-27 2000-06-06 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4506680A (en) * 1983-03-17 1985-03-26 Medtronic, Inc. Drug dispensing body implantable lead
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
ATE71147T1 (de) * 1984-05-11 1992-01-15 Berlex Lab Verfahren zur herstellung eines im wesentlichen nichtloeslichen polypetids unter verwendung nichtionischer detergentien.
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules

Also Published As

Publication number Publication date
JPH0822820B2 (ja) 1996-03-06
JPS6253928A (ja) 1987-03-09
IL79403A0 (en) 1986-10-31
DK173165B1 (da) 2000-02-21
KR870000924A (ko) 1987-03-10
MX173196B (es) 1994-02-07
NZ216832A (en) 1989-01-06
ATE84707T1 (de) 1993-02-15
DE3687551D1 (de) 1993-03-04
PT82978B (pt) 1988-07-01
EP0210039B1 (en) 1993-01-20
CN1026862C (zh) 1994-12-07
CN86105858A (zh) 1987-06-03
EP0210039A3 (en) 1988-07-06
IE861876L (en) 1987-01-15
DE3687551T2 (de) 1993-05-13
PT82978A (en) 1986-08-01
ES2002099A6 (es) 1988-07-16
KR930008952B1 (ko) 1993-09-17
EP0210039A2 (en) 1987-01-28
BR8603315A (pt) 1987-02-24
AU604639B2 (en) 1991-01-03
IE62302B1 (en) 1995-01-25
CA1288196C (en) 1991-08-27
JPH08205888A (ja) 1996-08-13
US4786501A (en) 1988-11-22
AU6020186A (en) 1987-01-22
DK336986A (da) 1987-01-16
ZA865271B (en) 1987-03-25

Similar Documents

Publication Publication Date Title
DK336986D0 (da) Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner
DE3782420T2 (de) Wachstumhormonzubereitungen mit verzoegerter wirkstoffabgabe fuer eine parenterale verabreichung und ihre verwendung.
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
DE68919213D1 (de) Polypeptidverbindungen mit wachstumshormonfreisetzender aktivität.
ES530202A0 (es) Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.
WO1988009780A3 (en) Polypeptide compounds having growth hormone releasing activity
DE68928528D1 (de) Verwendung von GnRH, LHRH oder ihre Derivate enthaltende Zubereitungen mit verzögerter Wirkstofffreisetzung
DE69209173D1 (de) Implantationzusammensetzungen, die biologisch aktive Proteine, Peptide oder Polypeptide enthalten
ATE238063T1 (de) Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor
MY100892A (en) Veterinary preparations.
ATE104143T1 (de) Kombination von phenaethanolamin und wachstumshormon.
TW360661B (en) Superactive GRF analogs
DE69513635T2 (de) Wässrige zubereitung mit verzögerter wirkstofffreigabe

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed